目的 探讨养血清脑颗粒联合银杏叶提取物注射液对脑梗死（CI）恢复期患者神经功能及认知功能的影响。方法 选取我院2024年7月-2025年11月收治的CI恢复期患者120例，按随机数字表法分2组，各组均60例；对照组予银杏叶提取物注射液治疗，治疗组基于对照组予养血清脑颗粒治疗，治疗周期均2周；对比2组疗效、神经功能、脑动脉血流速度、炎症指标、血液流变学指标、认知功能及不良反应。结果 治疗组总治疗有效率（95.00%）较对照组（81.67%）高，治疗后美国国立卫生研究院卒中量表（NIHSS）评分较对照组低（P＜0.05）；治疗组治疗后脑动脉平均血流速度（Vm）较对照组高，搏动指数（PI）、阻力指数（RI）、C反应蛋白（CRP）、同型半胱氨酸（Hcy）水平、血浆黏度、纤维蛋白原（FIB）水平、血小板最大聚集率水平较对照组低（P＜0.05）；治疗组治疗后简明精神状态检查量表（MMSE）评分较对照组高（P＜0.05）；组间不良反应相比无统计学差异（P＞0.05）。结论 养血清脑颗粒联合银杏叶提取物注射液治疗CI恢复期患者效果较好，可减轻神经功能缺损，提高脑动脉血流速度，降低炎症反应，调节血液流变学，改善认知功能。

目的 研究并分析星状神经节阻滞联合银杏叶提取物治疗颈源性头晕的临床效果。方法 选取周口骨科医院100例颈源性头晕的住院患者作为研究对象,于2022年6月—2023年6月期间内收治,根据入院顺序奇偶号将其分为对照组与观察组,各50例,对照组实行星状神经节阻滞治疗,观察组在对照组基础上联合使用银杏叶提取物治疗,对比两组患者的临床症状（头痛、眩晕、耳鸣、视物模糊）改善程度、颈部疼痛量表、临床效果和不良反应发生率。结果 治疗30 d后,观察组临床症状评分低于对照组（P<0.05）。两组治疗前的数字分级法评分差异无统计学意义（P>0.05）,治疗15 d与30 d时,观察组数字分级法评分评分均低于对照组（P<0.05）。观察组患者的治疗总有效率高于对照组（P<0.05）;治疗期间,观察组的并发症发生率低于对照组,比较差异有统计学意义（P<0.05）。结论 颈源性头晕患者使用星状神经节阻滞联合银杏叶提取物治疗,能够明显改善疾病症状,缓解颈部疼痛感,有效提高临床效果,同时降低不良反应发生率。

Objective To analyze the clinical study of stellate ganglion block combined with Ginkgo biloba extract to treat cervical dizziness．Methods A total of 100 hospitalized patients with cervical dizziness at Zhoukou Orthopedic Hospital were selected as the study subjects,who were admitted between June 2022 and June 2023．They were divided into a control group and an observation group based on the odd and even numbers of admission,with 50 cases in each group．The control group received stellate ganglion block treatment,while the observation group received a combination of Ginkgo biloba extract treatment on the basis of the control group,The degree of improvement in clinical symptoms（headache,dizziness,tinnitus,blurred vision）,neck pain scale,clinical efficacy,and incidence of adverse reactions were compared between two groups of patients．Results After 30 days of treatment,the clinical symptom score of the observation group was lower than that of the control group（P<0.05）．There was no statistically significant difference in the numerical grading scores between the two groups before treatment（P>0.05）．On the 15th and 30th day of treatment,the observation group had lower numerical grading scores than the control group（P<0.05）．The total effective rate of treatment in the observation group was higher than that in the control group（P<0.05）．During the treatment period,the incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant（P<0.05）．Conclusions The use of stellate ganglion block combined with Ginkgo biloba extract in the treatment of patients with cervicogenic dizziness can significantly improve their disease symptoms,significantly alleviate their neck pain,effectively improve the clinical effect,while reducing the incidence of adverse reactions．

目的 基于网络药理学方法预测银杏叶治疗心肌缺血的潜在靶点及信号通路。方法 利用 TCMSP 平台筛选生物利用度(OB)≥ 30% 和类药性(DL)≥ 0.18 的活性成分及作用靶点。利用GeneCards和OMIM数据库检索心肌缺血疾病相关靶点,并提取药物成分和心肌缺血疾病的共有靶点作为关键靶点。通过在线TRING平台构建PPI网络,并采用Cytoscape 软件构建可视化的“化合物-靶点-通路”网络,进一步进行GO 功能富集分析和KEGG通路富集分析。结果 筛选得到 27种潜在的药效成分,2 164个化合物靶点,531个心肌缺血相关靶基因。两者取交集后获得疾病-类药活性成分40个共同靶点,PPI 蛋白互作网络自由度较高的节点依次为:IL6、VEGFA、CASP3、MAPK8、MYC、NOS3。GO 功能富集分析得到42个 GO 条目,KEGG 通路富集分析得到42条信号通路。结论 银杏叶治疗心肌缺血主要GO 能力富集在半胱氨酸肽链内切酶活性,内肽酶活力,激活转录因子结合,DNA结合转录激活剂活性,RNA聚合酶II特异性等功能,调控TNF信号通路,糖尿病并发症的年龄愤怒信号, 细胞凋亡,PI3K-Akt信号通路等信号,进一步达到对心肌缺血疾病的治疗。

Objective To predict the potential targets and signal pathways of ginkgo leaf in the treatment of myocardial ischemia based on network pharmacology. Methods The active components and targets of bioavailability (OB) ≥ 30% and drug-like (DL) ≥ 0.18 were screened by TCMSP platform.The related targets of myocardial ischemic diseases were searched by GeneCards and OMIM database, the components and the common targets of myocardial ischemic diseases were extracted as the key targets. To build the PPI network through the online STRING platform, a visual “compound-target-pathway” network was constructed to further analyze the functional enrichment of GO and the enrichment of KEGG pathway. Results 27 potential active components, 2 164 compound targets and 531 myocardial ischemia related target genes were screened. After the intersection of the two, 40 common targets of disease-class active components were obtained. The nodes with higher degree of freedom of PPI protein interaction network were IL6、VEGFA、CASP3、MAPK8、MYC and NOS3.42 entries were obtained by GO functional enrichment analysis and 42 signal pathways were obtained by KEGG pathway enrichment analysis. Conclusion Ginkgo leaf may be a target of cysteine-type endopeptidase activity,endopeptidase activity,activating transcription factor binding,DNA-binding transcription activator activity, RNA polymerase II-specific function. TNF signaling pathway, AGE-RAGE signaling pathway in diabetic complications, apoptosis, PI3K-Akt signaling pathway were regualted to achieve the treatment of myocardial ischemia disease.